Sort
4,870 grants matching “glp 1”
Platelet Bioreactor for Treatment of Radiation-Induced Thrombocytopenia
$300,000Lea M Beaulieu · Stellular Bio, Inc. · R43 · FY2018 · AI
Selection and preclinical development of a bacteria-targeting, non-antibiotic lead candidate to improve cancer chemotherapy outcomes
$300,000Ward Peterson · Symberix, Inc. · R44 · FY2018 · CA
Pre-Clinical Development of Topical Pirenzepine for Treating Diabetic Neuropathy
$300,000Angela Hansen · Winsantor, Inc. · R44 · FY2016 · DK
Reducing Stroke by a Novel, Clot-dissolving Antibody
$300,000Paul H Kussie · Translational Sciences, Inc. · U44 · FY2011 · NS
Development of Estrogen Receptor B Selective Receptor Agonists to Treat Neuropath
$300,000Ethan Samuel Burstein · Acadia Pharmaceuticals, Inc. · U44 · FY2012 · NS
Novel dermal templates for prevention and treatment of biofilms in cutaneous wounds
$300,000Manav Mehta · Gel4med, Inc. · R43 · FY2019 · AI
Regulatory Mechanisms of Insulin Secretion
$300,000Mark A Rizzo · University Of Maryland Baltimore · R01 · FY2008 · DK
Prevention of Allergic Rhinitis with Topical Immunomodulating Antibodies
$300,000Randall M Goldblum · Chrysalis Biotherapeutics, Inc. · R41 · FY2011 · AI
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum
$300,000Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2009 · AI
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung
$300,000Robert Tarran · Eldec Pharmaceuticals, Inc. · R42 · FY2020 · AI
Pre-Clinical Evaluation of Antimalarial Natural Products from Carica papaya L.
$300,000Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2008 · AI
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
$300,000Valerie Humblet · Collagen Medical, Llc · R44 · FY2015 · CA
Antifungal Dermal Templates for Wound Healing
$300,000Manav Mehta · Gel4med, Inc. · R43 · FY2020 · AI
Novel antimicrobials in fighting carbapenem-resistant Klebsiella pneumoniae
$300,000Reen Wu · Effectorbio, Inc. · R43 · FY2023 · AI
A New Small-Molecule Kinase Inhibitor for Breast Cancer
$300,000Michael J Holtzman · Nupeak Therapeutics, Inc. · R41 · FY2018 · CA
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum
$300,000Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2008 · AI
Polynitroxylated Pegylated Hemoglobin for Traumatic Brian Injury Resuscitation
$300,000Carleton Hsia · Synzyme Technology, Inc. · U44 · FY2011 · NS
Development of Kv1.3 channel blocker ShK-186 as a therapy for multiple sclerosis
$300,000Shawn Patrick Iadonato · Kineta, Inc. · R43 · FY2011 · AI
Hypoglycemia Vagal Nerve Stimulation Therapy (HVNS Therapy)
$300,000Jon James Waataja · Reshape Lifesciences, Inc. · R43 · FY2022 · DK
Development of Estrogen Receptor B Selective Receptor Agonists to Treat Neuropath
$300,000Ethan Samuel Burstein · Acadia Pharmaceuticals, Inc. · U44 · FY2011 · NS
IND-enabling studies for eCD4-Ig as a long-acting recombinant protein therapeutic
$300,000Michael David Alpert · Emmune, Inc · R43 · FY2025 · AI
Platelet Bioreactor for Treatment of Radiation-Induced Thrombocytopenia
$300,000Lea M Beaulieu · Stellular Bio, Inc. · R43 · FY2017 · AI
Development of Orally Administered Peptide Hormones for Treatment of Diabetes and Obesity
$300,000Yifang Yang · Transira Therapeutics, Llc · R43 · FY2021 · DK
Oral formulation for novel inhibitor of Ras driven cancers
$300,000Joshua Canzoneri · Adt Pharmaceuticals, Llc · R43 · FY2017 · CA
Novel Ras inhibitor prodrug for colorectal cancer
$300,000Joshua Canzoneri · Adt Pharmaceuticals, Llc · R43 · FY2016 · CA